Related Compounds
Compounds connected by the same goals, effects, or research topics.
Compound Profile
Improves lipid profile but no added cardiovascular benefit with statins.
Review needed — Flushing; hepatotoxicity at high doses. Details
Continue reading
Safety
Flushing; hepatotoxicity at high doses.
Elevated caution
Caution level: Elevated. One caution category applies — read it before use.
Early signal that needs stronger human replication before practical claims.
Human clinical evidence: Not the primary signal
Mechanistic / preclinical: Mechanism mapped — Metabolic Regulation · HDL Increase · Vascular Function Support
Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.
Safety boundary: Safety note available — Flushing; hepatotoxicity at high doses.
Confidence estimate based on the design quality and consistency of published clinical trials.
Niacin has a preliminary evidence rating.
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Niacin Works
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
Continue exploring
Compounds connected by the same goals, effects, or research topics.
Botanicals connected by the same goals, effects, or research topics.
Deeper context, comparisons, and practical research paths.
Safety checks and cautions relevant to this decision.
Deeper context, comparisons, and practical research paths.
Compare side-by-side tradeoffs or verify active marker guidelines.
Free safety checklist
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Compound profile context
Niacin compound profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first format. Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.
When reviewing Niacin, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.
For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.